Drilldown: Medicines
Medicines > fda max 
:
4 mg/d (schizophrenia); 3 mg/d (AD agitation); 3 mg/d (MDD adjunct) or
600 mg/d
& routes:
oral
:
4 mg/d (schizophrenia); 3 mg/d (AD agitation); 3 mg/d (MDD adjunct) or
600 mg/d
& routes:
oral Use the filters below to narrow your results.
generic:
classes:
mechanism:
uses:
Schizophrenia (FDA-approved 2015). Adjunctive treatment of major depressive disorder (2015). '''Agitation associated with dementia due to Alzheimer disease''' (FDA-approved May 2023, first agent specifically approved for this problem). Investigational for PTSD (combined with sertraline). (1) ·
'"`UNIQ--vote-000009DF-QINU`"', '"`UNIQ--vote-000009E0-QINU`"', '"`UNIQ--vote-000009E1-QINU`"', '"`UNIQ--vote-000009E2-QINU`"', '"`UNIQ--vote-000009E3-QINU`"' (1)
starting dose:
preparations:
fda max: (Click arrow to add another value)
routes: (Click arrow to add another value)
duration:
bioavailability:
pregnancy:
Showing below up to 2 results in range #1 to #2.